About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 3,821–3,830 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 3,784 |
ChemElectroChem CHEMELECTROCHEM |
2196-0216 2196-0216 |
3.500 | 3.800 | Q2 | 20/44 | WILEY-V C H VERLAG GMBH |
| 3,784 |
Chinese Journal of Electrical Engineering CHINESE J ELECTR ENG |
2096-1529 2836-4619 |
3.500 | 0.000 | Q2 | 132/366 | CHINA MACHINE PRESS |
| 3,784 |
CLINICAL AND EXPERIMENTAL HYPERTENSION CLIN EXP HYPERTENS |
1064-1963 1525-6006 |
3.500 | 2.200 | Q2 | 26/98 | TAYLOR & FRANCIS INC |
| 3,784 |
CLINICAL AND EXPERIMENTAL MEDICINE CLIN EXP MED |
1591-8890 1591-9528 |
3.500 | 3.600 | Q2 | 68/195 | SPRINGER-VERLAG ITALIA SRL |
| 3,784 |
COMPLEMENTARY THERAPIES IN MEDICINE COMPLEMENT THER MED |
0965-2299 1873-6963 |
3.500 | 3.800 | Q1 | Oct-45 | CHURCHILL LIVINGSTONE |
| 3,784 |
COMPUTER VISION AND IMAGE UNDERSTANDING COMPUT VIS IMAGE UND |
1077-3142 1090-235X |
3.500 | 4.800 | Q2 | 132/366 | ACADEMIC PRESS INC ELSEVIER SCIENCE |
| 3,784 |
Construction Innovation-England CONSTR INNOV-ENGL |
1471-4175 1477-0857 |
3.500 | 3.900 | Q2 | 25/95 | EMERALD GROUP PUBLISHING LTD |
| 3,784 |
CURRENT CANCER DRUG TARGETS CURR CANCER DRUG TAR |
1568-0096 1873-5576 |
3.500 | 2.900 | Q2 | 106/326 | BENTHAM SCIENCE PUBL LTD |
| 3,784 |
CURRENT MEDICINAL CHEMISTRY CURR MED CHEM |
0929-8673 1875-533X |
3.500 | 4.000 | Q2 | 107/352 | BENTHAM SCIENCE PUBL LTD |
| 3,784 |
Current Opinion in Behavioral Sciences CURR OPIN BEHAV SCI |
2352-1546 2352-1554 |
3.500 | 5.900 | Q1 | 8/102 | ELSEVIER |